Melanoma risk during immunomodulating treatment
Sign Up to like & getrecommendations! Published in 2022 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000838
Abstract: Immunosuppressive therapy is standard for the treatment of inflammatory diseases and for minimizing rejection in transplant patients. However, immunosuppressant drugs are associated with an increased risk of certain cancers. In particular, melanoma is an immunogenic… read more here.
Keywords: immunomodulating treatment; melanoma; melanoma risk; risk immunomodulating ... See more keywords